Gout pill could be prime candidate to treat seriously ill COVID-19 patients says new study

THE UNPRECEDENTED scale of the vaccine rollout has proven an effective shield against infection. For those who do become infected and become seriously ill, however, current go-to treatments are massively limited. One new study has suggested the gout drug remdesivir could be a prime candidate to treat severely ill COVID-19 patients.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
More News: COVID-19 | Gout | Health | Study | Vaccines